Pentacosafluorotridecanoic Acid
Perfluorotridecanoic acid (PFTrDA) is a perfluoroalkyl substance (PFAS) . Embryo larval exposure of PFTrDA induces yolk sac edema and increases mRNA expression of thyroid hormone synthesis genes, including tshβ, in zebrafish when used at concentrations of 0.1 and 0.3 mg/L, respectively. PFTrDA (10 mg/kg) decreases serum testosterone and luteinizing hormone levels, testis palmitic acid, linoleic acid, and oleic acid levels, and the number of Leydig cells in rats in late puberty. Maternal plasma levels of PFTrDA during gestation are positively associated with the development of eczema in female, but not male, infants, and liver levels of PFTrDA are higher in cancerous human livers compared with non-cancerous human livers. It has been found in marine mammals.
Product Specifications
CAS Number
[72629-94-8]
Product Name Alternative
PFTrDA
UNSPSC
12352211
Hazard Statement
H302+H332-H351-H360-H362-H372
Target
TSH Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein
Applications
COVID-19-immunoregulation
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/pentacosafluorotridecanoic-acid.html
Smiles
OC(=O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F
Molecular Formula
C13HF25O2
Molecular Weight
664.11
Precautions
P260-P261-P263-P264-P270-P271-P280-P304+P340-P330-P405-P501
References & Citations
[1]Okada, et al. Prenatal exposure to perfluoroalkyl acids and allergic diseases in early childhood. Environ. Int. 65, 127-134 (2014) .
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items